hotspot -WSS

hotspot

author：hotspot 2025-10-01 01:49:54 - browse：5

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The haunting brain science of long Covid

knowledge

WSS

Roche’s Alnylam deal shows drug firms interested in heart drugs

What causes rare myocarditis in young men after Covid vaccines?

Listen: Your guide to Wegovy's blockbuster heart study

After John Oliver segment, STAT readers share their opioid

GOP presidential candidates start declaring their loyalty

Rise in cancer among younger people worries and puzzles doctors

knowledge

hotspot

focus

As demand for Covid shots wanes, Moderna seeks its next success

Faced with fears of OxyContin misuse, sales reps touted its safety

How to save PrEP access — and even expand it

Biogen says it will cut costs by $700 million, slash 1,000 jobs

How one medical school became remarkably diverse

Biden warns of ‘dark winter’ during final presidental debate

How to save PrEP access — and even expand it

The history of OxyContin, told through Purdue Pharma documents

Supreme Court strikes down use of affirmative action

The perfect storm of weather conditions that led to the devastating wildfires in Maui

leisure time

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Rise in cancer among younger people worries and puzzles doctors

Rise in cancer among younger people worries and puzzles doctors

How doctors’ personal politics affect patients

Why patients can’t get everything they want on drug pricing

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

knowledge

focus

knowledge

entertainment